29.05.2012European Antibody CongressYou are hereEventsLife science events European Antibody Congress
The European Antibody Congress is now 3-congresses in one in 2012, combining the very best of mAb discovery and development with the next generation of Bispecific and Multivalents and Antibody Drug Conjugates.
Showcasing major global trends, recent intra-market clinical progress, best practice and 1-2-1 partnering opportunities, this event delivers unrivalled industry participation across the antibody value chain.
4à6 de BioAlps - Selexis SA20.09.2017Les "4à6" de BioAlps sont une série d'événements organisés dans chacun des 7 cantons de Suisse occidentale.
Welcome To Health ValleyBuilding on skills honed over the centuries, western Switzerland has become a world leader in biotech.
Med Discovery SATherapeutics & Diagnostics, Proteins / PeptidesMed Discovery is a Swiss biopharmaceutical company dedicated to the discovery and the development of highly specific treatments for uro-genital cancers.
Our strategy is to develop protein drugs based on the optimization of natural proteins involved in the regulation of biological pathways.
To achieve this we are leveraging a unique in-house expertise in kallikreins, the biggest class of human proteases, combined with an international network in clinical urology.
Our proprietary technology platform to produce protease inhibitors allows Med Discovery to target cancers or other diseases where there is a lack of specific treatment.
Using this approach, Med Discovery intends to become a leading research and development biotech company in the uro-genital field, developing products both in-house and with appropriate partners.